AP3270A - Production method of intermediate compound for synthesizing medicament - Google Patents
Production method of intermediate compound for synthesizing medicamentInfo
- Publication number
- AP3270A AP3270A AP2013006763A AP2013006763A AP3270A AP 3270 A AP3270 A AP 3270A AP 2013006763 A AP2013006763 A AP 2013006763A AP 2013006763 A AP2013006763 A AP 2013006763A AP 3270 A AP3270 A AP 3270A
- Authority
- AP
- ARIPO
- Prior art keywords
- production method
- intermediate compound
- synthesizing
- medicament
- synthesizing medicament
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000002194 synthesizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20100086619 | 2010-09-03 | ||
| PCT/KR2011/006260 WO2012030106A2 (fr) | 2010-09-03 | 2011-08-25 | Procédé de production d'un composé intermédiaire pour la synthèse d'un médicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2013006763A0 AP2013006763A0 (en) | 2013-03-31 |
| AP3270A true AP3270A (en) | 2015-05-31 |
Family
ID=45023417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2013006763A AP3270A (en) | 2010-09-03 | 2011-08-25 | Production method of intermediate compound for synthesizing medicament |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8741927B2 (fr) |
| EP (1) | EP2611776B1 (fr) |
| JP (1) | JP5705985B2 (fr) |
| KR (1) | KR101378984B1 (fr) |
| CN (1) | CN103080088B (fr) |
| AP (1) | AP3270A (fr) |
| AR (1) | AR082881A1 (fr) |
| AU (1) | AU2011296767B2 (fr) |
| BR (1) | BR112013004988B1 (fr) |
| CA (1) | CA2810393C (fr) |
| CL (1) | CL2013000589A1 (fr) |
| CO (1) | CO6700826A2 (fr) |
| DK (1) | DK2611776T3 (fr) |
| EA (1) | EA022500B1 (fr) |
| EC (1) | ECSP13012471A (fr) |
| ES (1) | ES2607089T3 (fr) |
| HU (1) | HUE032484T2 (fr) |
| IL (1) | IL224954B (fr) |
| MA (1) | MA34490B1 (fr) |
| MX (1) | MX2013002277A (fr) |
| MY (1) | MY157423A (fr) |
| NZ (1) | NZ607694A (fr) |
| PE (1) | PE20131128A1 (fr) |
| PH (1) | PH12013500343A1 (fr) |
| PL (1) | PL2611776T3 (fr) |
| PT (1) | PT2611776T (fr) |
| SG (1) | SG188329A1 (fr) |
| SI (1) | SI2611776T1 (fr) |
| TW (1) | TWI438188B (fr) |
| UA (1) | UA107721C2 (fr) |
| UY (1) | UY33589A (fr) |
| WO (1) | WO2012030106A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2995612A1 (fr) * | 2014-09-12 | 2016-03-16 | Université de Strasbourg | Nouveaux acides aminés non naturels, leur procédé de préparation et leurs utilisations |
| KR102068754B1 (ko) * | 2017-04-20 | 2020-01-21 | 주식회사 엘지화학 | 의약품 합성용 중간체 화합물의 제조 방법 |
| MX2020003543A (es) * | 2017-09-28 | 2020-07-29 | Lg Chemical Ltd | Metodo de produccion de un compuesto intermediario para sintetizar un medicamento. |
| CN111164071A (zh) * | 2017-09-28 | 2020-05-15 | 株式会社Lg化学 | 用于合成药物的中间体化合物的制备方法 |
| MX2020005099A (es) * | 2017-11-16 | 2020-08-13 | Lg Chemical Ltd | Metodo de produccion de un compuesto intermedio para sintetizar un medicamento. |
| KR102184129B1 (ko) * | 2017-11-16 | 2020-11-27 | 주식회사 엘지화학 | 의약품 합성용 중간체 화합물의 제조 방법 |
| CN113861061A (zh) * | 2021-10-25 | 2021-12-31 | 成都市科隆化学品有限公司 | 一种不含无机铵盐的氨基酸酰胺盐酸盐及其合成方法 |
| KR20250155700A (ko) | 2024-04-24 | 2025-10-31 | 주식회사 다산제약 | 제미글립틴 산부가염 제조방법 및 이를 유효성분으로 포함하는 dpp-4 저해용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4456768A (en) * | 1980-10-08 | 1984-06-26 | The University Of Chicago | Chemical synthesis |
| US5556982A (en) * | 1985-01-14 | 1996-09-17 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| DE3705272A1 (de) * | 1987-02-19 | 1988-09-01 | Basf Ag | Verfahren zur reduktion von mono- und dicarbonsaeuren |
| US5417023A (en) * | 1993-12-27 | 1995-05-23 | Mandish; Theodore O. | Building panel apparatus and method |
| CN1420881A (zh) * | 2000-03-17 | 2003-05-28 | 布里斯托尔-迈尔斯斯奎布药品公司 | 作为基质金属蛋白酶和TNF-α抑制剂的β-氨基酸衍生物 |
| TWI357902B (en) * | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
| CL2007002293A1 (es) * | 2006-08-09 | 2008-02-22 | Smithkline Beecham Corp | Compuestos derivados de 4-(5-oxo-pirrolidin-amino)-benzonitrilo, moduladores de los receptores de progesterona; composicion farmaceutica; y uso para tratar endometriosis, fibroma uterino, dismenorrea, menorragia, parto prematuro, esterilidad y para p |
| KR20080071476A (ko) * | 2007-01-30 | 2008-08-04 | 주식회사 엘지생명과학 | 신규한 디펩티딜 펩티데이즈 iv(dpp-iv) 저해제 |
| CN101903386B (zh) * | 2007-12-21 | 2015-04-22 | 株式会社Lg生命科学 | 抑制二肽基肽酶-ⅳ的化合物、其制备方法以及含所述化合物作为活性剂的药物组合物 |
-
2011
- 2011-08-25 PL PL11822081T patent/PL2611776T3/pl unknown
- 2011-08-25 EA EA201390336A patent/EA022500B1/ru unknown
- 2011-08-25 UA UAA201302600A patent/UA107721C2/ru unknown
- 2011-08-25 AP AP2013006763A patent/AP3270A/xx active
- 2011-08-25 HU HUE11822081A patent/HUE032484T2/en unknown
- 2011-08-25 ES ES11822081.3T patent/ES2607089T3/es active Active
- 2011-08-25 MY MYPI2013000673A patent/MY157423A/en unknown
- 2011-08-25 MA MA35699A patent/MA34490B1/fr unknown
- 2011-08-25 SG SG2013014931A patent/SG188329A1/en unknown
- 2011-08-25 CA CA2810393A patent/CA2810393C/fr active Active
- 2011-08-25 US US13/820,197 patent/US8741927B2/en active Active
- 2011-08-25 NZ NZ607694A patent/NZ607694A/en unknown
- 2011-08-25 PH PH1/2013/500343A patent/PH12013500343A1/en unknown
- 2011-08-25 CN CN201180041893.9A patent/CN103080088B/zh active Active
- 2011-08-25 PE PE2013000351A patent/PE20131128A1/es active IP Right Grant
- 2011-08-25 AU AU2011296767A patent/AU2011296767B2/en active Active
- 2011-08-25 DK DK11822081.3T patent/DK2611776T3/en active
- 2011-08-25 BR BR112013004988-0A patent/BR112013004988B1/pt active IP Right Grant
- 2011-08-25 JP JP2013527003A patent/JP5705985B2/ja active Active
- 2011-08-25 WO PCT/KR2011/006260 patent/WO2012030106A2/fr not_active Ceased
- 2011-08-25 MX MX2013002277A patent/MX2013002277A/es active IP Right Grant
- 2011-08-25 EP EP11822081.3A patent/EP2611776B1/fr active Active
- 2011-08-25 PT PT118220813T patent/PT2611776T/pt unknown
- 2011-08-25 SI SI201131045A patent/SI2611776T1/sl unknown
- 2011-09-02 TW TW100131640A patent/TWI438188B/zh active
- 2011-09-02 KR KR1020110089110A patent/KR101378984B1/ko active Active
- 2011-09-02 AR ARP110103214A patent/AR082881A1/es active IP Right Grant
- 2011-09-02 UY UY0001033589A patent/UY33589A/es unknown
-
2013
- 2013-02-27 IL IL224954A patent/IL224954B/en active IP Right Grant
- 2013-03-01 CO CO13042032A patent/CO6700826A2/es unknown
- 2013-03-01 CL CL2013000589A patent/CL2013000589A1/es unknown
- 2013-03-01 EC ECSP13012471 patent/ECSP13012471A/es unknown
Non-Patent Citations (2)
| Title |
|---|
| DAVID G. WASHBURN ET AL.: 'Discovery or orally active, pyrrolidinone-based progesterone receptor partial agonist' BIOORGANIC & MEDICINAL CHEMISTRY LETTERS vol. 19, no. 16, 2009, pages 4664 - 4667, XP026419052 * |
| MONICA LOPEZ-GARCIA ET AL.: 'Synthesis of (R)-3,4- diaminobutanoic acid by desymmetrization of dimethyl 3-(benzylamino)-glutarate through enzymatic ammonolysis' JOURNAL OF ORGANIC CHEMISTRY vol. 68, no. 2, 2003, pages 648 - 651, XP055105976 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268953B (en) | A process to form cycloalkylcarboxamido indole compounds | |
| PL2609120T3 (pl) | Ulepszony sposób wytwarzania sugammadeksu | |
| IL221299A (en) | A process for the preparation of Rifaximine pallimorphic configuration | |
| PL2789617T3 (pl) | Sposób wytwarzania enancjomerów związków spiro-oksyndolowych | |
| IL221170A0 (en) | Processes of synthesizing dihydropyridophthalazinone derivatives | |
| PL2632930T3 (pl) | Sposób pozyskiwania ligniny | |
| ZA201303568B (en) | Method of producing a ppi-containing pharmaceutical preparation | |
| PL2542531T3 (pl) | Sposób syntezy fipronilu | |
| IL248217B (en) | A method for the production of inganol-3-englate | |
| ZA201209370B (en) | Method for manufacturing of quinoline-3-carboxamides | |
| IL224954B (en) | A production method of an intermediate compound for the synthesis of a drug | |
| ZA201308852B (en) | Process of making beta-hydroxyamino compounds | |
| IL226677A (en) | Beta-amyloid production compounds | |
| EP2668176A2 (fr) | Nouveau procédé de synthèse de polyphénols | |
| EP2589662A4 (fr) | Procédé de production d'une substance utile | |
| IL222474A0 (en) | Method of synthesis | |
| HUE044066T2 (hu) | Eljárás metilén-difenil-diizocianát elõállítására | |
| EP2647623A4 (fr) | Procédé de production d'un composé isothiocyanate | |
| EP2468799A4 (fr) | Procédé de production de composé polysiloxane modifié | |
| EP2522648A4 (fr) | Procede de production d'un compose de difluorocyclopropane | |
| EP2423212A4 (fr) | Procédé de fabrication d'un composé 2-azaadamantane à partir d'un composé bicyclocarbamate | |
| LT2585182T (lt) | Farmakologiniu požiūriu grynų kristalų gamybos būdas | |
| EP2537851A4 (fr) | Procédé de préparation de composés b-glycosides | |
| EP2583960A4 (fr) | Procédé de fabrication d'intermédiaire de composition de carbodiimide cyclique | |
| GB201021753D0 (en) | Process for producing 2-alkyl-cyclopent-2-enone compounds |